G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis
Atherosclerosis, the underlying cause of the majority of cardiovascular diseases (CVDs), is a lipid-driven, inflammatory disease of the large arteries. Gold standard therapy with statins and the more recently developed proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have improved he...
Main Authors: | Emiel P. C. van der Vorst, Linsey J. F. Peters, Madeleine Müller, Selin Gencer, Yi Yan, Christian Weber, Yvonne Döring |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00531/full |
Similar Items
-
Inflammatory Chemokines in Atherosclerosis
by: Selin Gencer, et al.
Published: (2021-01-01) -
Small Things Matter: Relevance of MicroRNAs in Cardiovascular Disease
by: Linsey J. F. Peters, et al.
Published: (2020-07-01) -
MIF and CXCL12 in cardiovascular diseases: functional differences and similarities
by: Emiel eVan Der Vorst, et al.
Published: (2015-07-01) -
Immunomodulatory Nanomedicine for the Treatment of Atherosclerosis
by: Linsey J. F. Peters, et al.
Published: (2021-07-01) -
Calcium-Sensing Receptor (CaSR), Its Impact on Inflammation and the Consequences on Cardiovascular Health
by: Sai Sahana Sundararaman, et al.
Published: (2021-03-01)